In vivo studies of the release of adenine 5′-nucleotides, adenosine, and its metabolites from the rat brain

Drug Development Research

Volumn 58, Issue 4, 2003, Pages 412-419

  Phillis, John W ^a   O'Regan, Michael H ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF DETROIT MERCY   (United States)

Author keywords

Adenine; Adenosine; Cerebral cortex; Hypoxemia; Ischemia; Metabolism; Nucleotides; Release; Transporters

Indexed keywords

1,4 DIHYDROPYRIDINE; 2 (2 HYDROXY 3 NONYLADENINE); ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE DEAMINASE; ADENOSINE DEAMINASE INHIBITOR; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ALLOPURINOL; DILAZEP; DIPYRIDAMOLE; HYPOXANTHINE; INOSINE; LIDOFLAZINE; NIFEDIPINE; NITROBENZYLTHIOINOSINE; NUCLEOSIDE PHOSPHORYLASE; NUCLEOTIDASE; OXIPURINOL; PENTOSTATIN; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; SOLUFLAZINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; URIC ACID; XANTHINE; XANTHINE OXIDASE;

BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN METABOLISM; CELL MEMBRANE TRANSPORT; CELL SWELLING; CEREBROSPINAL FLUID; CONFERENCE PAPER; DEPOLARIZATION; ENERGY METABOLISM; ENZYME MECHANISM; HORMONE METABOLISM; HORMONE RECEPTOR INTERACTION; HORMONE TRANSPORT; IN VIVO STUDY; INTERSTITIAL FLUID; NEUROMODULATION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; POTASSIUM CURRENT; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN METABOLISM; PROTEIN SECRETION; PURINE METABOLISM; RECEPTOR INTRINSIC ACTIVITY;

EID: 0038726946     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10173     Document Type: Conference Paper

References (77)

1. Anderson CM, Xiong W, Young JD, Cass CE, Parkinson FE. 1996. Demonstration of the existence of mRNAs encoding N1/cif and N2/cit sodium/nucleoside cotransporters in rat brain. Mol Brain Res 42:358-361.
2. Anderson CM, Baldwin SA, Young JD, Cass CE, Parkinson FE. 1999a. Distribution of mRNA encoding a nitrobenzylthioinosine-insensitive nucleoside transporter (ENT2) in rat brain. Mol Brain Res 70:293-297.
3. Anderson CM, Xiong W, Geiger JD, Young JD, Cass CE, Baldwin SA, Parkinson FE. 1999b. Distribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporters (ENT1) in brain. J Neurochem 73:867-873.
4. Araque A, Carmignoto G, Haydon PG. 2001. Dynamic signaling between astrocytes and neurons. Ann Rev Physiol 63:795-813.
5. Ballarin M, Fredholm BB, Ambrosio S, Mahy N. 1991. Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol Scand 142:97-103.
6. Barraco RA, Walter GA, Polasek PM, Phillis JW. 1991. Purine concentrations in the cerebrospinal fluid of unanesthetized rats during and after hypoxia. Neurochem Int 18:243-248.
7. Berne RM. 1963. Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol 204:317-322.
8. Berne RM, Rubio R, Curnish RR. 1974. Release of adenosine from ischemic brain. Effect on cerebral vascular resistance and incorporation into cerebral adenine nucleotides. Circ Res 35:262-271.
9. Burnstock G. 1972. Purinergic nerves. Pharmacol Rev 24:509-581.
10. Cotrina ML, Lin JH, Alvez-Rodriguez A, Liu S, Li J, Azmi-Ghadimi H, Kang J, Naus CC, Nedergaard M. 1998. Connexins regulate calcium signaling by controlling ATP release. Proc Natl Acad Sci USA 95:15735-15740.
11. Cotrina ML, Lin JH-C, Lopez-Garcia JC, Naus CC, Nedergaard M. 2000. ATP-mediated glia signaling. J Neurosci 20:2835-2844.
12. Drury AN, Szent-Gyorgi A. 1929. The physiological activity of adenine compounds with especial reference to their action on the mammalian heart. J Physiol (Lond) 68:213-237.
13. Edwards FA. 1996. Features of P2X receptor-mediated synapses in the rat brain: why doesn't ATP kill the postsynaptic cell? Ciba Found Symp 198:278-286.
14. Edwards FA, Gibb AJ, Colquhoun D. 1992. ATP receptor-mediated synaptic currents in the central nervous system. Nature 359:144-147.
15. Feldberg W, Sherwood SL. 1954. Injections of drugs into the lateral ventricle of the cat. J Physiol (Lond) 123:148-167.
16. Fields RD, Stevens B. 2000. ATP: an extracellular signaling molecule between neurons and glia. Trends Neurosci 23:625-633.
17. Gilbertsen RB, Scott ME, Dong MK, Kossare LM, Bennett MK, Schrier DJ, Sircar JC. 1987. Preliminary report on 8-amino-9-(2-thienylmethyl)guanine (PD 119,229), a novel and potent purine nucleoside phosphorylase inhibitor. Agents Actions 21:272-274.
18. Greene RW, Haas HL. 1991. The electrophysiology of adenosine in the mammalian central nervous system. Prog Neurobiol 36:329-341.
19. Guthrie PB, Knappenberger J, Segal M, Bennett MV, Charles AC, Kater SB. 1999. ATP release from astrocytes mediates glial calcium waves. J Neurosci 19:520-528.
20. - conductances in C127 cells. J Physiol (Lond) 523:1-11.
21. 6 rat glia cells by a common anion efflux pump. J Biol Chem 266:1641-1645.
22. Holton P. 1959. The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves. J Physiol (Lond) 145:494-504.
23. Koyama T, Oike M, Ito Y. 2001. Involvement of Rho-kinase and tyrosine kinase in hypotonic stress-induced ATP release in bovine aortic endothelial cells. J Physiol (Lond) 532:759-769.
24. Kuroda Y, McIlwain H. 1974. Uptake and release of (14C) adenine derivatives at beds of mammalian cortical synaptosomes in a superfusion system. J Neurochem 22:691-699.
25. Kuroda Y, Saito M, Kobayashi K. 1976. Concomitant changes in cyclic AMP level and postsynaptic potentials of olfactory cortex slices induced by adenosine derivatives. Brain Res 109:196-201.
26. Latini S, Corsi C, Pedata F, Pepeu G. 1995. The source of brain adenosine outflow during ischemia and electrical stimulation. Neurochem Int 27:239-244.
27. Latini S, Pedata F. 2001. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 79:463-484.
28. Li H, Henry JL. 2000. Adenosine action on interneurons and synaptic transmission onto interneurons in rat hippocampus in vitro. Eur J Pharmacol 407:237-244.
29. Marley E, Nistico G. 1972. Effects of catecholamines and adenosine derivatives given into the brain of fowls. Br J Pharmacol 46:619-636.
30. Martinez M, Fernandez E, Frank A, Guaza C, De La Fuente M, Hernanz A. 1999. Increased cerebrospinal fluid cyclic AMP levels in Alzheimer's disease. Brain Res 846:265-267.
31. Mihaylova-Todorova S, Todorov LD, Westfall DP. 2001. Correlation between the release of sympathetic neurotransmitter ATP and soluble nucleotidases from the guinea pig vas deferens. J Pharmacol Exp Ther 296:64-70.
32. Mihaylova-Todorova ST, Todorov LD, Westfall DP. 2002. Enzyme kinetics and pharmacological characterization of nucleotidases released from the guinea pig isolated vas deferens during nerve stimulation: evidence for a soluble ecto-nucleoside triphosphate disphosphohydrolase-like ATPase and a soluble ecto-5′-nucleotidase-like AMPase. J Pharmacol Exp Ther 302:992-1001.
33. Nedergaard M. 1994. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science 263:1768-1771.
34. Okada Y, Kuroda Y. 1980. Inhibitory action of adenosine and adenosine analogs on neurotransmission in the olfactory cortex slice of guinea pig - structure activity relationships. Eur J Pharmacol 61:137-146.
35. Okada Y, Maeno E, Shimizu T, Dezaki K, Wang J, Morishima S. 2001. Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease. J Physiol (Lond) 532:3-16.
36. O'Regan MH, Phillis JW, Walter GA. 1989. The effects of xanthine oxidase inhibitors, allopurinol and oxypurinol, on the pattern of purine release from hypoxic rat cerebral cortex. Neurochem Int 14:91-99.
37. m 5′-nucleotidase from rat brain cytosolic fraction: purification, kinetic properties, and description of regulation by a novel factor that increases sensitivity to inhibition by ATP and ADP. J Neurochem 67:795-804.
38. Park TS, Gidday JM. 1990. Effect of dipyridamole on cerebral extracellular adenosine level in vivo. J Cereb Blood Flow Metab 10:424-427.
39. + depolarization, tetrodotoxin, and NMDA receptor inhibition on extracellular adenosine levels in rat striatum. Eur J Pharmacol 234:61-65.
40. Phillips E, Newsholme EA. 1979. Maximum activities, properties and distribution of 5′-nucleotidase, adenosine kinase and adenosine deaminase in rat and human brain. J Neurochem 33:553-558.
41. Phillis JW, Clough-Helfman C. 1990. Oxypurinol, but not deox ycoformycin, administered post-ischemia, protects against CA1 hippocampal damage in the gerbil. Int J Purine Pyrimid Res 1:31-35.
42. Phillis JW, Edstrom JP. 1976. Effects of adenosine analogs on rat cerebral cortical neurons. Life Sci 19:1041-1054.
43. Phillis JW, Kostopoulos GK. 1975. Adenosine as a putative transmitter in the cerebral cortex: studies with potentiators and antagonists. Life Sci 17:1085-1094.
44. Phillis JW, O'Regan MH. 2002. Evidence for swelling-induced adenosine and adenine nucleotide release in rat cerebral cortex exposed to monocarboxylate-containing or hypotonic artificial cerebrospinal fluids. Neurochem Int 40:619-635.
45. Phillis JW, Kostopoulos GK, Limacher JJ. 1974. Depression of corticospinal cells by various purines and pyrimidines. Can J Physiol Pharmacol 52:1226-1229.
46. Phillis JW, Edstrom JP, Kostopoulos GK, Kirkpatrick JR. 1979. Effects of adenosine and adenine nucleotides on synaptic transmission in the cerebral cortex. Can J Physiol Pharmacol 57:1289-1312.
47. Phillis JW, Swanson TH, Barraco RA. 1984. Interactions between adenosine and nifedipine in the rat cerebral cortex. Neurochem Int 4:586-592.
48. Phillis JW, DeLong RE, Towner JK. 1986. The effects of nifedipine and felodipine on cerebral blood flow during anoxic episodes. Stroke 17:229-234.
49. Phillis JW, Walter GA, O'Regan MH, Stair RE. 1987. Increases in cerebral cortical perfusate adenosine and inosine concentrations during hypoxia and ischemia. J Cereb Blood Flow Metab 7:679-686.
50. Phillis JW, O'Regan MH, Walter GA. 1988a. Effects of deoxycoformycin on adenosine, inosine, hypoxanthine, xanthine and uric acid release from the hypoxemic rat cerebral cortex. J Cereb Blood Flow Metab 8:733-741.
51. Phillis JW, O'Regan MH, Walter GA. 1988b. Effects of nifedipine and felodipine on adenosine and inosine release from the hypoxaemic rat cerebral cortex. J Cereb Blood Flow Metab 8:179-185.
52. Phillis JW, O'Regan MH, Walter GA. 1989. Effect of two nucleoside transport inhibitors, dipyridamole and soluflazine, on purine release from the rat cerebral cortex. Brain Res 481:309-316.
53. Phillis JW, Walter GA, Simpson RE. 1990. A purine nucleoside phosphorylase inhibitor, 8-amino-9-(2-thienylmethyl)guanine, enhances purine release from the rat cerebral cortex. Int J Purine Pyrimidine Res 1:19-23.
54. Phillis JW, Walter GA, Simpson RE. 1991a. Release of purines and transmitter amino acids into cerebral cortical perfusates during and following transient ischemia. Int J Purine Pyrimidine Res 2:41-48.
55. Phillis JW, Walter GA, Simpson RE. 1991b. Brain adenosine and transmitter amino acid release from the ischemic rat cerebral cortex: effects of the adenosine deaminase inhibitor deoxycoformycin. J Neurochem 56:644-650.
56. Phillis JW, O'Regan MH, Perkins LM. 1993. Adenosine 5′-triphosphate release from the normoxic and hypoxic in vivo rat cerebral cortex. Neurosci Lett 151:94-96.
57. Phillis JW, Perkins LM, Smith-Barbour M, O'Regan MH. 1995. Oxypurinol-enhanced post-ischemic recovery of the rat brain involves preservation of adenine nucleotides. J Neurochem 64:2177-2184.
58. Richardson PJ, Brown SJ. 1987. ATP release from affinity purified rat cholinergic nerve terminals. J Neurochem 48:622-630.
59. Robertson SJ, Edwards FA. 1998. ATP and glutamate are released from separate neurons in the rat medial habenula nucleus: frequency dependence and adenosine-mediated inhibition of release. J Physiol (Lond) 508:691-701.
60. Robertson SJ, Ennion SJ, Evans RJ, Edwards FA. 2001. Synaptic P2X receptors. Curr Opin Neurobiol 11:378-386.
61. Salter MW, De Konnick Y, Henry JL. 1993. Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn. Progr Neurobiol 41:125-156.
62. Sciotti VM, Van Wylen DGL. 1993. Increases in interstitial adenosine and cerebral blood flow with an inhibition of adenosine kinase and adenosine deaminase. J Cereb Blood Flow Metab 13:201-207.
63. Skladanowski AC, Newby AC. 1991. 5′-Nucleotidases involved in adenosine formation. In: Imai S, Nakazawa M. Role of adenosine and adenine nucleotides in the biological system. Amsterdam: Elsevier Science Publishers. p 289-300.
64. Sneddon P, Westfall DP, Todorov LD, Mihaylova-Todorova S, Westfall DP, Kennedy C. 1999. Modulation of purinergic neurotransmission. Progr Brain Res 120:11-20.
65. 3H adenosine and its derivatives from cat sensorimotor cortex. Life Sci 17:551-556.
66. Thorn JA, Jarvis SM. 1996. Adenosine transporters. Gen Pharmacol 27:613-620.
67. Todorov LD, Mihaylova-Todorova S, Westfall TD, Sneddon P, Kennedy C, Bjur RA, Westfall DP. 1997. Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature 387:76-79.
68. Trexler EB, Bennett MV, Bargiello TA, Verselis VK. 1996. Voltage gating and permeation in a gap junction hemichannel. Proc Natl Acad Sci USA 93:5836-5841.
69. Van Reempts J, Van Deuren B, Haseldonckx M, Van De Ven M, Thone F, Borgers M. 1988. Purine nucleoside phosphorylase: a histochemical marker for glial cells. Brain Res 462:142-147.
70. Van Wylen DGL, Park TS, Rubio R, Berne RM. 1986. Increases in cerebral interstitial fluid adenosine concentration during hypoxia, local potassium infusion, and ischemia. J Cereb Blood Flow Metab 6:522-528.
71. + and by veratridine. J Neurochem 30:329-336.
72. Wieraszko A, Goldsmith G, Seyfried TN. 1989. Stimulation-dependent release of adenosine triphosphate from hippocampal slices. Brain Res 485;244-250.
73. Wu PH, Phillis JW. 1978. Distribution and release of adenosine triphosphate in rat brain. Neurochem Res 3:563-571.
74. Yao SYM, Ng AML, Muzyka WR, Griffiths M, Cass CE, Baldwin SA, Young JD. 1997. Molecular cloning and functional characterization of nitrobenzylthioinosine NBMPR-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. J Biol Chem 272:28423-28430.
75. Zhang J, Kornecki E, Jackman J, Ehrlich YH. 1988. ATP secretion and extracellular protein phosphorylation by CNS neurons in primary culture. Brain Res Bull 21:459-464.
76. Zimmermann H. 1994. Signaling via ATP in the nervous system. Trends Neurosci 17:420-426.
77. Zimmermann H. 1996. Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Progr Neurobiol 49:589-618.